Current Main Activities:
Researcher, Uganda Malaria Surveillance Project, Kampala, Uganda. Conduct studies on antimalarial drug efficacy, safety and tolerability, compile reports, including statistical and resistance trends, to track the spread of antimalarial drug resistance.
Education and Training:
Institute of Public Health, Makerere University, Kampala, Uganda M.P.H (Masters of Public Health) 2001
Makerere University Medical School, Kampala, Uganda. MBChB (Bachelor of Medicine and Surgery) 1994
Publications:
- Moses R. Kamya, Adoke Yeka, Hasifa Bukirwa, Myers Lugemwa, John B. Rwakimari, Sarah G. Staedke, Ambrose O. Talisuna, Bryan Greenhouse, Francois Nosten, Philip J. Rosenthal, Fred Wabwire-Mangen, Grant Dorsey: Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial, PLoS Clinical Tials May 2007 e20.
- Hasifa B, Adoke Y, Moses RK, Ambrose T, Kristin B, Nathan B, John BR, Philip JR, Fred WM, Grant D, Sarah GS. “Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda” PLOS Clinical Trials. 2006 May e7.
- Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G. “Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.” PLoS Med. 2005 Jul;2(7):e190.
- Bakyaita N, Dorsey G, Yeka A, Banek K, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya S, Kilian A, Reingold A, Rosenthal PJ, Wabwire-Mangen F. “Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.” Am J Trop Med Hyg. 2005 May;72(5):573-80.
- Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya S, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G. Artemisinin versus non-artemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Medicine 2005;2(7):e190.
- Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. “Effect of HIV infection on malaria treatment outcomes in Uganda; A population based study.” JID 2006:193:9-15
- Lee SA, Yeka A, Nsobya SL, Dokomajilar C, Rosenthal PJ, Talisuna A, Dorsey G. “Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at seven sites in Uganda.” J Infect Dis. 2006 Apr 15;193(8):1160-3
- Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, Dokomajilar C, Rosenthal PJ, Dorsey G. “Geographic differences in antimalarial drug efficacy explained by differences in endemicity and not molecular markers of drug resistance.” J Infect Dis. 2006 Apr 1;193(7):978-86
Presentations
- “Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomlicated Malaria in Ugandan Children” at Fifth AMANET Biennial Conference, Zanzibar, Tanzania 26th February 2007.
- “Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomlicated Malaria in Ugandan Children” at ASTMH 55th annual Meeting, Atlanta Georgia 13 - 14th November 2006.
- “Multi Site Trial of Combination antimalarial therapies: Assessment of Efficacy and Safety in Uganda at fourth MIM Pan-African Malaria Conference held in Yaoundé, Cameroon November 13-18, 2005.
- “Artemisinin verses non-artemisinin combination therapy for uncomplicated malaria: randomised clinical trials from four sites in Uganda” at ASTMH 53rd annual Meeting, Miami Beach Florida 10th November 2004
- “Multi-site trial of combination antimalarial therapy: evaluation of efficacy, safety and tolerability in Uganda” at 2nd Forum for EDCTP, Durban South Africa 5th October 2005
- Monitoring the efficacy of ACT’s in Uganda at the dissemination workshop on “Implementing ACTs in Uganda” and findings of “A Review of the Implementation of the HBMF strategy in UPHOLD supported Districts”10th September 2005, Hotel Africana, Uganda
|
